Search alternatives:
point decrease » point increase (Expand Search)
ns decrease » _ decrease (Expand Search), we decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
ns decrease » _ decrease (Expand Search), we decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
1681
-
1682
-
1683
-
1684
Effect of substrate binding on hNaa50p dynamics.
Published 2012“…C: Map of the differences of correlation between simulations of hNaa50p-MLG and hNaa50p-apo. Red dots indicate an increase in correlation, while blue dots indicate a decrease. …”
-
1685
-
1686
-
1687
Decreased expression of genes related to cholesterol biosynthesis and lipogenesis in PCA.
Published 2012“…<i>EBP</i> expression was significantly decreased in the PCA subtypes TF, FFA and CCCA but not in DC, FD or LPP. …”
-
1688
IC<sub>50</sub> is distinct for diclofenac, ibuprofen, and ASA.
Published 2015“…The assays showed a significant linear concentration-dependent decrease of cell viability, which significantly differed between (A) ibuprofen (IC<sub>50</sub>, 1 mM) and (B) diclofenac (IC<sub>50</sub>, 0.1 mM). …”
-
1689
-
1690
Myosin phosphatase and RhoA-activated kinase modulate neurotransmitter release by regulating SNAP-25 of SNARE complex
Published 2017“…Inhibition of PP1 with tautomycetin increased, whereas inhibition of ROK by H1152, decreased the phosphorylation of SNAP-25 at Thr138 in B50 cells, in cortical synaptosomes, and in brain slices. …”
-
1691
PowerPoint Slides for: Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease
Published 2017“…<b><i>Methods:</i></b> A phase 2a, multicenter, randomized, double-blind, placebo-controlled, dose-ranging trial (NCT01381094) was undertaken in adults with anemia secondary to CKD stage 3 or 4. …”
-
1692
-
1693
-
1694
-
1695
-
1696
-
1697
-
1698
-
1699
-
1700